The scientific literature now recognizes that metabolic endotoxemia is an underlying factor in many serious health conditions. In this interview, research microbiologist Kiran Krishnan describes how and why this condition occurs and how to prevent and reverse it. Krishnan has spent several years with hands-on research and development in the fields of molecular medicine and microbiology at the University of Iowa. He is currently involved in 16 novel human clinical trials on probiotics and the human microbiome.
Kiran Krishnan is a Research Microbiologist and has been involved in the dietary supplement and nutrition market for the past 18 years. He comes from a University research background having spent several years with hands-on R&D in the fields of molecular medicine and microbiology at the University of Iowa. Kiran established a Clinical Research Organization where he designed and conducted dozens of human clinical trials in human nutrition. Kiran is also a co-founder and partner in Nu Science Trading, LLC.; a nutritional technology development and research company. Kiran is also a co-founder and Chief Scientific Officer at Microbiome Labs. He is a frequent lecturer on the Human Microbiome at Medical and Nutrition Conferences. He is an expert guest on National and Satellite radio, has appeared in several international documentaries and has been a guest speaker on several International Health Summits as a microbiome expert. He is currently involved in 16 novel human clinical trials on probiotics and the human microbiome. Kiran is also on the Scientific Advisory Board or a Science Advisor for 7 other companies in the industry.
Microbiome Labs was originally established in 2013 as Physicians Exclusive as an organization focused on providing probiotic bacteriotherapy. In the past several years, its business model has grown and so has public awareness for gut health issues. Microbiome Labs comes to you as an all-inclusive resource center designed to address the needs of physicians and health care practitioners across the globe.
Microbiome Labs’ goal is to provide integrative solutions and clinical research data to address indications that stem from digestive and immune health issues. It hopes to encourage other supplement companies to raise the bar of the supplement industry as a whole. In 2018, Microbiome Labs attended over 148 conferences, initiated and/or completed 14 clinical trials, and provided key solutions to thousands of practitioners, changing over 344,000 lives… and counting. View MBL’s video to learn more about its story.
To learn more about our flagship product, MegaSporeBioticTM, click here.